Nordhealth AS (OSL:NORDH)

Norway · Delayed Price · Currency is NOK

26.20

-0.40 (-1.50%)

Nov 13, 2026, 9:51 AM CET

Nordhealth AS Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	55.44	50.84	45.68	36.83	31.05	20.3
Revenue Growth	9.93%	11.31%	24.03%	18.60%	52.96%	60.04%
Gross Profit	12.96	13.54	15.67	9.16	4.01	6.67
Operating Income	-14.76	-12.47	-7.73	-11.39	-14.68	-4.46
Net Income	-15.85	-12.68	-7.67	-11.13	-14.26	-4.73
Earnings Per Share	-	-0.16	-0.10	-	-0.18	-0.06
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Veterinary	33.15	28.43	20.59	15.47	11.63
Therapy	16.3	15.44	14.45	15.58	8.67
Other	1.39	1.8	1.78	-	-
Total	50.84	45.68	36.83	31.05	20.3

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	11.58	14.7	19.62	22.17	39.2	72.67
Total Debt	-	-	-	-	0.03	0.05
Net Cash (Debt)	11.58	14.7	19.62	22.17	39.17	72.62
Net Cash Growth	-29.64%	-25.07%	-11.50%	-43.40%	-46.06%	3986.11%
Net Cash Per Share	-	0.19	0.25	-	0.49	0.91

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	0.02	0.72	1.85	-5.22	-6.3	5.57
Capital Expenditures	-4.99	-5.09	-5.02	-5.72	-6.8	-3.38
Free Cash Flow	-4.98	-4.37	-3.17	-10.95	-13.1	2.19
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '26 Sep 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	23.37%	26.63%	34.30%	24.88%	12.93%	32.83%
Operating Margin	-26.62%	-24.53%	-16.91%	-30.92%	-47.27%	-21.96%
Pretax Margin	-27.41%	-24.18%	-14.53%	-29.34%	-45.50%	-22.89%
Profit Margin	-28.59%	-24.94%	-16.80%	-30.23%	-45.94%	-23.30%
FCF Margin	-8.98%	-8.60%	-6.94%	-29.72%	-42.20%	10.79%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 15, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	-	44.38	150.51	52.81	52.81	94.36
P/FCF Ratio	-	-	-	-	-	145.84
PS Ratio	3.42	4.93	6.54	4.75	5.45	15.73